Flare Therapeutics Inc.

THERAtRAME

The company develops small molecule inhibitors targeting tRNA epitranscriptomics to treat resistant and immune-refractory cancers for patients with limited therapeutic options.

Fore Bio

This biotechnology company develops precision oncology therapies and small-molecule inhibitors for patients with unaddressed tumour mutations and hard-to-treat cancers.

Flindr Therapeutics

This company develops small molecule inhibitors for the precision treatment of cancer patients with specific tumor and host factors.

Kronos Bio

This biopharmaceutical company develops small molecule therapeutics targeting transcription factors for patients with cancer and autoimmune diseases.

Type6 Therapeutics

This deep-tech company develops kinase inhibitors for cancer treatment, intercepting enzymes in their inactive states to address drug resistance for patients with aggressive tumours.

Cartography Biosciences

This deep-tech company develops precision cancer therapeutics and drug targets for healthcare providers using computational biology and machine learning platforms.

Rewrite Therapeutics

This deep-tech company develops DNA writing and genome editing tools for biotechnology firms to treat genetic diseases.

Circle Pharma

This deep-tech company develops macrocycle-based therapies to treat cancer and other serious illnesses for patients requiring targeted medical treatments.